Bcl-xL-mediated changes in metabolic pathways of breast cancer cells: From survival in the blood stream to organ-specific metastasis

American Journal of Pathology

Volumn 167, Issue 4, 2005, Pages 1125-1137

  España, Laura ^a   Martín, Berta ^a   Aragüés, Ramón ^b   Chiva, Cristina ^c   Oliva, Baldo ^b   Andreu, David ^c   Sierra, Angels ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL REDUCTASE; CARBONYL REDUCTASE 3; ENOLASE; ENOLASE 1; PEROXIREDOXIN; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PHOSPHOTRANSFERASE; PROTEIN BCL XL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD FLOW; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER TRANSPLANTATION; CELL METABOLISM; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 26244466587     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61201-1     Document Type: Article

References (59)

1. McCawley LJ, Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000, 6:149-156
2. Wells A: Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000, 78:31-101
3. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458
4. Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004, 4:11-22
5. Goodison S, Kawai K, Hihara J, Jiang P, Yang M, Urquidi V, Hoffman RM, Tarin D: Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res 2003, 9:3808-3814
6. Yefenof E, Picker LJ, Scheuermann RH, Tucker TF, Vitetta ES: Cancer dormancy: isolation and characterization of dormant lymphoma cells. Proc Natl Acad Sci USA 1993, 90:1829-1833
7. Holmgreen L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153
8. Karrison TG, Ferguson DJ, Meier P: Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 1999, 91:80-85
9. Hart IR: Perspective: tumour spread the problems of latency. J Pathol 1999, 187:91-94
10. Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA: From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003, 100:7737-7742
11. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536
12. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ: Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100:15901-15905
13. Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54
14. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70
15. Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature 2001, 411:375-379
16. Ladeda V, Adam AP, Puricelli L, Bal de Kier Joffe E: Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis. Breast Cancer Res Treat 2001, 69:39-51
17. Bernards R, Weinberg RA: A progression puzzle. Nature 2002, 418:823
18. Fernandez Y, Espana L, Manas S, Fabra A, Sierra A: Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ 2000, 7:350-359
19. Rubio N, Espana L, Fernandez Y, Blanco J, Sierra A: Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity. Lab Invest 2001, 81:725-734
20. Espana L, Fernandez Y, Rubio N, Torregrosa A, Blanco J, Sierra A: Overexpression of Bcl-x(L) in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 2004, 87:33-44
21. Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL: Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 2002, 21:7611-7618
22. Celis JE, Gromov P: Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003, 3:9-15
23. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858
24. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P: Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 1999, 34:105-116
25. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B: STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 2003, 31:258-261
26. Enright AJ, Iliopoulos I, Kyrpides NC, Ouzounis CA: Protein interaction maps for complete genomes based on gene fusion events. Nature 1999, 402:86-90
27. Pellegrini M, Marcotte EM, Thompson MJ, Eisenberg D, Yeates TO: Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc Natl Acad Sci USA 1999, 96:4285-4288
28. Dandekar T, Snel B, Huynen M, Bork P: Conservation of gene order: a fingerprint of proteins that physically interact. Trends Biochem Sci 1998, 23:324-328
29. Yu H, Luscombe NM, Lu HX, Zhu X, Xia Y, Man JD, Bertin N, Chung S, Vidal M, Gerstein M: Annotation transfer between genomes: protein-protein interologs and protein-DNA regulogs. Genome Res 2004, 14:1107-1118
30. Salwinski L, Miller CS, Smith AJ, Pettit FK, Sowie JU, Eisenberg D: The Database of Interacting Proteins: 2004 update. Nucleic Acids Res 2004, 32:0449-0451
31. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549
32. Danial NN, Korsmeyer SJ: Cell death: critical control points. Cell 2004, 116:205-219
33. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW: Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature 2004, 428:332-337
34. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson Jr HF, Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-7393
35. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999, 96:9212-9217
36. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235
37. Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, Louisot P, Lunardi J: Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 2002, 277:19396-19401
38. Wood ZA, Poole LB, Karplus PA: Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003, 300:650-653
39. Nonn L, Berggren M, Powis G: Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 2003, 1:682-689
40. Wonsey DR, Zeller KI, Dang CV: The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc Natl Acad Sci USA 2002, 99:6649-6654
41. Tse GM, Ma TK: Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation. Cancer 2000, 90:286-291
42. Cook RM, Burke BJ, Buchhagen DL, Minna JD, Miller YE: Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer. J Biol Chem 1993, 268:17010-17017
43. Li C, Fox CJ, Master SR, Bindokas VP, Chodosh LA, Thompson CB: Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc Natl Acad Sci USA 2002, 99:9830-9835
44. McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, Thompson CB, Hay N, Chandel NS: Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 2002, 22:94-104
45. Hermeking H: The 14-3-3 cancer connection. Nat Rev Cancer 2003, 3:931-943
46. Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, Louis H, Boilly B, Nurcombe V, Revillion F, Peyrat JP, Hondermarck H: Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res 2001, 61:76-80
47. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N, Gotoh Y: JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 2004, 23:1889-1899
48. Holmfeldt P, Brattsand G, Gullberg M: MAP4 counteracts microtubule catastrophe promotion but not tubulin-sequestering activity in intact cells. Curr Biol 2002, 12:1034-1039
49. Amayed P, Pantaloni D, Carlier MF: The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration. J Biol Chem 2002, 277:22718-22724
50. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R, Bieche I: Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer 2000, 82:142-150
51. Brattsand G: Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 2000, 83:311-318
52. Huang J, Tan PH, Thiyagarajan J, Bay BH: Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 2003, 16:558-565
53. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin III EF, Zhao Y, Steeg PS: Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002, 62:6740-6749
54. Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC: Proteomic analysis for the early detection and rational treatment of cancer-realistic hope? Ann Oncol 2005, 16:16-22
55. Page MJ, Amess B, Townsend RR, Parekh R, Herath A, Brusten L, Zvelebil MJ, Stein RC, Waterfield MD, Davies SC, O'Hare MJ: Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc Natl Acad Sci USA 1999, 96:12589-12594
56. Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 2003, 113:821-823
57. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB, Recant WM: Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 1997, 3:230-237
58. Liotta LA, Kohn EC: Cancer's deadly signature. Nat Genet 2003, 33:10-11
59. Montel V, Huang T-Y, Mose E, Pestonjamasp K, Tarin D: Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol 2005, 166:1565-1579